Late occurrence of bilateral tuberculous-like epididymo-orchitis after intravesical bacille Calmette-Guérin therapy for superficial bladder carcinoma

Urology

Volumn 65, Issue 1, 2005, Pages

  Falkensammer, C ^a   Gozzi, C ^a   Hager, M ^b   Maier, H ^b   Bartsch, G ^a   Holtl L ^a   Rehder, P ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; CIPROFLOXACIN; ETHAMBUTOL; ISONIAZID; PYRAZINAMIDE; RIFAMPICIN;

AGED; ARTICLE; BLADDER CARCINOMA; CANCER IMMUNOTHERAPY; CANCER RADIOTHERAPY; CASE REPORT; ECHOGRAPHY; EPIDIDYMIS DISEASE; EPIDIDYMITIS; HISTOPATHOLOGY; HUMAN; INFLAMMATION; MAINTENANCE THERAPY; MALE; ORCHIECTOMY; ORCHITIS; PAIN; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SINGLE DRUG DOSE; SUPERFICIAL CANCER; SURGICAL TECHNIQUE; TESTIS DISEASE; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; UROGENITAL TUBERCULOSIS;

ADENOCARCINOMA; ADMINISTRATION, INTRAVESICAL; AGED; AGED, 80 AND OVER; BCG VACCINE; CARCINOMA IN SITU; CARCINOMA, TRANSITIONAL CELL; COMBINED MODALITY THERAPY; EPIDIDYMITIS; HUMANS; INSTILLATION, DRUG; MALE; MYCOBACTERIUM BOVIS; NEOPLASMS, MULTIPLE PRIMARY; ORCHIECTOMY; ORCHITIS; PROSTATIC NEOPLASMS; TIME FACTORS; TRANSURETHRAL RESECTION OF PROSTATE; TUBERCULOMA; TUBERCULOSIS, MALE GENITAL; URINARY BLADDER NEOPLASMS;

EID: 12844272094     PISSN: 00904295     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.urology.2004.07.027     Document Type: Article

References (11)

1. H.W. Herr, D.M. Schwalb, Z.F. Zhang Intravesical bacillus Calmette-Guérin therapy prevents tumor progression and death from superficial bladder cancer ten-year follow-up of a prospective randomized trial J Clin Oncol 13 1995 1404
2. M.S. Cookson, H.W. Herr, Z.F. Zhang The treated natural history of high risk superficial bladder cancer 15-year outcome J Urol 158 1997 62 67
3. H.W. Herr, R.A. Badalament, D.A. Amato Superficial bladder cancer treated with bacillus Calmette-Guérin a multivariate analysis of factors affecting tumor progression J Urol 141 1989 22 29
4. S. Prescott, A.M. Jackson, S.J. Hawkyard Mechanisms of action of intravesical bacille Calmette-Guérin local immune mechanisms Clin Infect Dis 31 suppl 3 2000 91 93
5. D.L. Lamm, V.D. Stogdill, B.J. Stogdill Complications of bacillus Calmette-Guérin immunotherapy in 1,278 patients with bladder cancer J Urol 135 1986 272 274
6. I. Akira, U. Toyoaki, Y. Hideyuki Sufficient prophylactic efficacy with minor adverse effects by intravesical instillation of low-dose bacillus Calmette-Guérin for superficial bladder cancer recurrence Int J Urol 10 2003 183 189
7. D.L. Lamm Efficacy and safety of bacille Calmette Guérin immunotherapy in superficial bladder cancer Clin Infect Dis 31 suppl 3 2000 86 90
8. J.J. Menke, J.R. Heins Epididymo-orchitis following intravesical bacillus Calmette-Guérin therapy Ann Pharmacother 34 2000 479 482
9. B.G. Gardner, A.L. Zietman, W.U. Shipley Late normal tissue sequelae in the second decade after high dose radiation therapy with combined photons and conformal protons for locally advanced prostate cancer J Urol 167 2002 123 126
10. G.S. Merrick, W.M. Butle, B.G. Tollenaar The dosimetry of prostate brachytherapy-induced urethral strictures Int J Radiat Oncol Biol Phys 52 2002 461 468
11. F.A. Vicini, L.L. Kestin, A.A. Martinez Use of conformal high-dose rate brachytherapy for management of patients with prostate cancer optimizing dose escalation Tech Urol 6 2000 135 145